Safety and Immunogenicity of Cat-allergen Intralymphatic Immunotherapy in Patients With Cat Allergy With and Without Asthma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Allergic Rhinitis · Allergic Asthma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • University Hospital Zurich, Zurich, Switzerland

    Contact: Study coordinator (Carole Guillet, MD) · Carole.Guillet@usz.ch · +41 43 253 1063
    Contact: Principal Investigator (Claudia V.L. Lang, MD)